Drug & medication recalls Moderate risk

Test PROCYP recalled over sterility concerns

Recall date
April 8, 2019
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Official notice title
Customceutical Compounding recalls Test PROCYP (TESTOSTERONE CYPIONATE 200MG/ML TESTOSTERONE PROPIONATE 20MG/ML), 5 ML MULTIDOSE VIAL INJ COMPOUNDED. Cust…
Recall number
D-1260-2019
FDA classification
Class II
Brand / firm
Customceutical Compounding
Sold / distributed
U.S.A. Nationwide

Why it was recalled

Lack of assurance of sterility for injectables and solutions intended to be sterile.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Test PROCYP (TESTOSTERONE CYPIONATE 200MG/ML TESTOSTERONE PROPIONATE 20MG/ML), 5 ML MULTIDOSE VIAL INJ COMPOUNDED. Customceutical Compounding 4611 E. Shea Blvd. Bldg 3 180, Phoenix, AZ 85028 Ph. 480 516 0272

Get recall alerts

Free email alert whenever Customceutical Compounding has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Customceutical Compounding